Altered plasma exosome miRNAs and novel potential biomarkers in pediatric fulminant myocarditis

Xinyue Zhang1, Ruling Yang1, Mengjie Ma1

  • 1Department of Pediatric Cardiology, Shandong Provincial Hospital, Shandong University, Jinan, China.

Genomics
|April 16, 2023
PubMed

Insights

Exosomes carrying microRNAs (miRNAs) impact fulminant myocarditis (FM) development. Plasma exosome miRNA profiles in pediatric FM revealed specific biomarkers, including hsa-miR-146a-5p, offering diagnostic potential.

Area of Science:

  • Cardiovascular Research
  • Immunology
  • Molecular Biology

Background:

  • Exosomes mediate intercellular communication via microRNAs (miRNAs), influencing diseases like fulminant myocarditis (FM).
  • Understanding miRNA profiles in pediatric FM is crucial for elucidating disease mechanisms.

Purpose of the Study:

  • To investigate the plasma exosome miRNA profile in pediatric FM.
  • To identify specific miRNA biomarkers and regulatory networks involved in FM pathogenesis.

Main Methods:

  • Small RNA microarray analysis of plasma exosomes from pediatric FM patients.
  • Bioinformatic analysis to identify differentially expressed miRNAs and target genes.
  • Quantitative real-time PCR (qRT-PCR) validation of specific miRNAs.

Main Results:

  • Identified 266 differentially expressed miRNAs (197 upregulated, 69 downregulated) in pediatric FM exosomes.
  • Established competing endogenous RNA (ceRNA) networks involving lncRNAs, circRNAs, miRNAs, and mRNAs.
  • Validated elevated expression of hsa-miR-146a-5p, hsa-miR-23a-3p, and hsa-miR-27a-3p; hsa-miR-146a-5p demonstrated high diagnostic sensitivity and specificity.

Conclusions:

  • Plasma exosome miRNAs play a significant regulatory role between immune and cardiac cells in pediatric FM.
  • Specific exosome miRNAs, particularly hsa-miR-146a-5p, serve as potential diagnostic biomarkers for FM.
  • This study provides novel research targets for understanding and treating pediatric FM.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
14
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
212
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
10
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K